Document Detail

The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.
MedLine Citation:
PMID:  6144706     Owner:  NLM     Status:  MEDLINE    
The influence of inflammatory bowel disease (IBD) and its therapy upon pregnancy is a frequent consideration before and after conception. We looked at the influence of disease activity and drug therapy during pregnancy on fetal outcome in 147 pregnancies in 124 women. Patients were divided into two groups; 46 (28 ulcerative colitis, 18 Crohn's disease) who received drug treatment during pregnancy, and 101 (42 ulcerative colitis, 59 Crohn's disease) who received no treatment. The frequency of fetal complications was higher than in the general population in the "treated" patients, but was not higher than in patients with IBD who received no drug treatment. Active IBD was present in 43% of the treated patients whose pregnancies resulted in fetal complications. Of patients with Crohn's disease whose pregnancies resulted in fetal complications, active IBD was present in 62.5%. Thus, our experience suggests that patients with IBD who receive therapy during pregnancy are at greater risk of fetal complications than the average population, but that disease activity is more likely to be responsible for this risk than drug treatment. This risk is much more evident in active Crohn's disease than in ulcerative colitis.
P J Baiocco; B I Korelitz
Related Documents :
9566676 - Relapse of wegener's granulomatosis in the first trimester of pregnancy: a case report.
1167046 - Complement component analysis in angiodema. diagnostic value.
7914776 - Idiopathic autoimmune hemolytic anemia during pregnancy.
19086876 - Pregnancy in parkinson's disease: case report and discussion.
7227926 - Growth of the fetal pigtailed macaque (macaca nemestrina) i. cephalofacial dimensions.
2686896 - The perinatal management of central nervous system anomalies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical gastroenterology     Volume:  6     ISSN:  0192-0790     ISO Abbreviation:  J. Clin. Gastroenterol.     Publication Date:  1984 Jun 
Date Detail:
Created Date:  1984-07-09     Completed Date:  1984-07-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7910017     Medline TA:  J Clin Gastroenterol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  211-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortion, Spontaneous / epidemiology
Colitis, Ulcerative / drug therapy*
Congenital Abnormalities / epidemiology
Crohn Disease / drug therapy*
Fetal Death / epidemiology
Immunosuppressive Agents / adverse effects
Infant, Newborn
Infant, Premature
Pregnancy Complications / drug therapy*
Steroids / adverse effects
Sulfasalazine / adverse effects
Reg. No./Substance:
0/Immunosuppressive Agents; 0/Steroids; 599-79-1/Sulfasalazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Muscarinic receptors and [3H]inositol incorporation in a rat sympathetic ganglion.
Next Document:  Phenotypic heterogeneity of antisyngeneic tumor killer cells (ASTK) generated in allogeneic mixed ly...